efficacy

Metilfenidato e ADHD

Carucci S

2021/5 — pag. 325-328 — DOI

Methylphenidate is the first-choice medication for the treatment of ADHD in children and adolescents. Over the past two decades, several randomised controlled trials re-peatedly showed its efficacy on both the core symptoms and the quality of life be...

L’epidemiologia che “conta” nelle scelte vaccinali: il caso della pertosse in neonati e lattanti

F. Marchetti, C. Guiducci, R. Angelini

2018/8 — pag. 495-500

From June to August 2018, 6 infants with pertussis aged between 1 and 9 months (4 were 3 months old, and the other two 1 month and 9 months old respectively) were admitted to a General Paediatrics Operating Unit. Their hospitalization period lasted...

Valutazione dell’efficacia di un percorso terapeutico-educazionale nel migliorare il controllo dell’asma in bambini e adolescenti

S. Guarnaccia, M. Bianchi, E. D’Agata, G. Boldini, A. Pluda, A. Boldi, A. Clavenna, M. Cartabia, M. Bonati

2012/9 — pag. 600-602

Aim - To evaluate whether the therapeutic-educational programme “Io e l’Asma”, addressed to asthmatic children/adolescents and their families would improve asthma control and implement asthma guidelines in an Italian setting in which the prevalen...

L’uso del miele nella tosse acuta

D. Sambugaro, F. Fusco

2012/5 — pag. 329-330

Vaccinare i neonati contro l’influenza stagionale?

M. Bonati

2012/1 — pag. 46-48

Vaccination against seasonal influenza is recognized worldwide as the main strategy for prevention and control. However, efficacy and effectiveness of influenza vaccines, both in people aged ≥65 years and in children, are lower than believed. P...

Profilo epidemiologico delle ADR in pediatria

A. Clavenna, M. Bonati

2009/8 — pag. 501-507

A meta-analysis of 8 prospective studies performed in the United States and Europe in the 2001-2007 period estimated that the incidence of ADRs in hospitalised children is 10.9% and in paediatric outpatients 1.0%. The contribution of ADRs to the ho...

Il vaccino contro il papillomavirus umano: efficacia dichiarata ed efficacia dimostrata

S. Di Mario, M. Bergamini, D. Spettoli, V. Basevi, N. Magrini

2007/9 — pag. 562-571

The recent introduction in the European market of the tetravalent vaccine against Human Papillomavirus raises some concerns on the opportunity to start a national vaccination campaign. In this article an analysis of the currently available evidence, ...

Vaccini anti-rotavirus. quale? quando? perché? per chi?

M. Fontana

2007/3 — pag. 173-175

Two new Rotavirus vaccines are being dispensed soon in Italy. They differ strongly in composition and suggested schedule. Available studies do not allow direct comparisons (severity scales for gastroenteritis are different, as are the cut-off point...

Efficacia e sicurezza del trattamento antifebbrile realizzato con due farmaci alternati

2006/6 — pag. 387-389

I farmaci antidepressivi nei bambini e negli adolescenti

F. Marchetti, L. Travan, M. Lazzerini

2005/6 — pag. 377-382

The increased use of antidepressant drugs in children and adolescents in the last years and the reports of suicides and self aggressive behaviours, especially among SSRI users, highlight the need for safety and efficacy evaluation of these drugs in...

Un intervento nutrizionale a basso costo ed alto successoL'esperienza del St Mary's Hospital di Lacor, Uganda

L. Greco, J. Belungi , K. Amodu, R. Iriso, B. Corrado

2004/9

Un intervento nutrizionale a basso costo e alto successo

2004/9 — pag. 583-585

An evaluation was made of a nutritional mix based on traditional food at the pediatric nutrition Unit at St. Mary's Hospital in Lacor, Uganda. 96 children with severe malnutrition were given a food mixture to complement the Unicef formula. The use...

Tacrolimus unguento

M. Lazzerini, F. Marchetti, G. Longo

2004/2 — pag. 102-107

The safety and efficacy of tacrolimus - a macrolide with immunosuppressive properties - were proven in atopic dermatitis in several trials versus placebo and in two trials versus topical steroids. The drug, as a 0.03% ointment, has been now approve...